News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Related Content
Trending on PharmExec
1
Launch is Just the Beginning: Rare Disease Care Requires Durability
2
Novartis to Layoff 322 NJ Employees: Report
3
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
4
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
5